Development and validation of a novel radiosensitivity signature in human breast cancer

Clinical Cancer Research

Volumn 21, Issue 16, 2015, Pages 3667-3677

  Speers, Corey ^a   Zhao, Shuang ^a   Liu, Meilan ^a   Bartelink, Harry ^b   Pierce, Lori J ^a,c   Feng, Felix Y ^a,c,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; BUB1 RELATED PROTEIN; RAD51 PROTEIN; SMALL INTERFERING RNA; TUMOR PROTEIN;

AREA UNDER THE CURVE; ARTICLE; ATM GENE; BREAST CANCER; BREAST CANCER CELL LINE; BUB1 GENE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL CYCLE ARREST; CELL SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DTL GENE; GENE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HUMAN; IONIZING RADIATION; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PARTIAL MASTECTOMY; PATIENT IDENTIFICATION; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; RAD51 GENE; RADIATION RESPONSE; RADIATION SENSITIVITY SIGNATURE; RADIOLOGICAL PARAMETERS; RADIOSENSITIVITY; RECEIVER OPERATING CHARACTERISTIC; RND3 GENE; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SURVIVAL TIME; SURVIVING FRACTION; TACC1 GENE; VALIDATION STUDY; ADJUVANT RADIOTHERAPY; BIOSYNTHESIS; BREAST NEOPLASMS; FEMALE; FRANCE; GENE EXPRESSION REGULATION; GENETICS; NETHERLANDS; PATHOLOGY; PROGNOSIS; RADIATION TOLERANCE; TUMOR CELL LINE; TUMOR RECURRENCE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; FRANCE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NETHERLANDS; PROGNOSIS; RADIATION TOLERANCE; RADIOTHERAPY, ADJUVANT;

EID: 84942856319     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-2898     Document Type: Article

References (31)

1. American Cancer Society, Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society; 2007 [Internet].
2. Early Breast Cancer Trialists' Collaborative G Darby S, McGale P, Correa C, Taylor C, Arriagada R, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: metaanalysis of individual patient data for 10, 801 women in 17 randomised trials. Lancet 2011;378:1707-16.
3. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-74.
4. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003;100:8418-23.
5. Cancer Genome Atlas N. Comprehensive molecular portraits of human breast tumours. Nature 2012;490:61-70.
6. Kyndi M, Sorensen FB, Knudsen H, OvergaardM, Nielsen HM, Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish breast cancer cooperative group. J Clin Oncol 2008;26:1419-26.
7. Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H. Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 2010;28:1684-91.
8. Eschrich SA, Fulp WJ, Pawitan Y, Foekens JA, Smid M, Martens JW, et al. Validation of a radiosensitivity molecular signature in breast cancer. Clin Cancer Res 2012;18:5134-43.
9. Naderi A, Teschendorff AE, Barbosa-Morais NL, Pinder SE, Green AR, Powe DG, et al. A gene-expression signature to predict survival in breast cancer across independent data sets. Oncogene 2007;26:1507-16.
10. Torres-Roca JF, Eschrich S, Zhao H, Bloom G, Sung J, McCarthy S, et al. Prediction of radiation sensitivity using a gene expression classifier. Cancer Res 2005;65:7169-76.
11. ServantN, BolletMA, HalfwerkH, Bleakley K, Kreike B, Jacob L, et al. Search for a gene expression signature of breast cancer local recurrence in young women. Clin Cancer Res 2012;18:1704-15.
12. Lupe K, Truong PT, Alexander C, Lesperance M, Speers C, Tyldesley S. Subsets of women with close or positive margins after breast-conserving surgery with high local recurrence risk despite breast plus boost radiotherapy. Int J Radiat Oncol Biol Phys 2011;81:e561-8.
13. Tramm T, Mohammed H, Myhre S, Kyndi M, Alsner J, Borresen-Dale AL, et al. Development and validation of a gene profile predicting benefit of postmastectomy radiotherapy in patients with high-risk breast cancer: a study of gene expression in the DBCG82bc Cohort. Clin Cancer Res 2014;20:5272-80.
14. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. NEngl J Med 2002;347:1999-2009.
15. Han S, Brenner JC, Sabolch A, JacksonW, Speers C, Wilder-Romans K, et al. Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition. Neoplasia. 2013;15:1207-17.
16. Gill S, Loprinzi C, Kennecke H, Grothey A, Nelson G, Woods R, et al. Prognosticweb-based models for stage II and III colon cancer: a population and clinical trials-based validation of numeracy and adjuvant! online. Cancer 2011;117:4155-65.
17. Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat 2012;133:831-41.
18. Arvold ND, Taghian AG, Niemierko A, Abi Raad RF, Sreedhara M, Nguyen PL, et al. Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy. J Clin Oncol 2011;29:3885-91.
19. Fertil B, Malaise EP. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 1985;11:1699-707.
20. Yang W, Soares J, Greninger P, Edelman EJ, Lightfoot H, Forbes S, et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res 2013;41:D955-61.
21. Bastien RR, Rodriguez-Lescure A, Ebbert MT, Prat A, Munarriz B, Rowe L, et al. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers. BMC Med Genomics 2012;5:44.
22. Ambrogi F, Biganzoli E, Querzoli P, Ferretti S, Boracchi P, Alberti S, et al. Molecular subtyping of breast cancer from traditional tumor marker profiles using parallel clustering methods. Clin Cancer Res 2006;12:781-90.
23. Hu X, Stern HM, Ge L, O'Brien C, Haydu L, Honchell CD, et al. Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol Cancer Res 2009;7:511-22.
24. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006;10:515-27.
25. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans E, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;366:2087-106.
26. Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. Mutational landscape and significance across 12 major cancer types. Nature 2013;502:333-9.
27. Lawrence MS, Stojanov P, Mermel CH, Robinson JT, Garraway LA, Golub TR, et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 2014;505:495-501.
28. Wistuba II, Behrens C, Milchgrub S, Syed S, Ahmadian M, Virmani AK, et al. Comparison of features of human breast cancer cell lines and their corresponding tumors. Clin Cancer Res 1998;4:2931-8.
29. Boeckman HJ, Trego KS, Turchi JJ. Cisplatin sensitizes cancer cells to ionizing radiation via inhibition of nonhomologous end joining. Mol Cancer Res 2005;3:277-85.
30. Lawrence TS, Blackstock AW, McGinn C. The mechanism of action of radiosensitization of conventional chemotherapeutic agents. Semin Radiat Oncol 2003;13:13-21.
31. Simon RM, Paik S, Hayes DF. Use of archived specimens in evaluation of prognostic and predictive biomarkers. J Natl Cancer Inst 2009;101:1446-52.